Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis

The aim of this work was to evaluate the efficacy and safety of botulinum toxin A (BTX-A) treatment in patients with neurogenic detrusor overactivity. PUBMED, EMBASE, and Cochrane Library were identified on 13 May 2017 to identify relevant randomized controlled trials. All data obtained were analyze...

Full description

Bibliographic Details
Main Authors: Shang-Jun Wu, Yu-Qiong Xu, Zheng-Yan Gao, Zhi-Peng Wang, Feng Zhao, Lin Liu, Sheng Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Renal Failure
Subjects:
Online Access:http://dx.doi.org/10.1080/0886022X.2019.1655448